cytoreductive


Also found in: Dictionary.
Related to cytoreductive: cytoreductive therapy

cytoreductive

 [si″to-re-duk´tiv]
reducing the number of cells, as in surgery for a tumor; see also debulking.

cytoreductive

/cy·to·re·duc·tive/ (-re-duk´tiv) reducing the number of cells.

cytoreduction

(sīt″ō-rĕ-dŭk′shŭn) [″ + ″]
Cellular killing, usually of cancerous cell clones, with chemotherapy.
cytoreductive (-dŭk′-tĭv), adjective
References in periodicals archive ?
In JAK2 V617F-positive ET patients with CVST, contemporary antithrombotic and cytoreductive therapies might be a satisfactory treatment option for preventing rethrombosis.
It has long been held as a central dogma that primary cytoreductive surgery (PCS) is the preferred initial treatment for women with newly diagnosed ovarian cancer.
Among 594 women with advanced ovarian cancer treated at one of six major comprehensive cancer centers, median overall survival (OS) for women with stage IIIC cancers treated with neoadjuvant chemotherapy (NACT) was 33 months, compared with 43 months for women treated with primary cytoreductive surgery (PCS), reported Larissa A.
sup][19] In Cases II and III, no obvious complications of cytoreductive surgery with HIPEC occurred within postoperative 30 days.
The standard treatment for EOC is radical cytoreductive surgery and subsequent systemic chemotherapy if needed.
Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer.
Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
The cancer expert specializes in combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of gastrointestinal tumors that have spread throughout the abdominal cavity.
The standard care for ovarian cancer is a combination of cytoreductive surgery and platinum-based chemotherapy (Kim et al.
Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
2007) Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and cMet, in experimental models of anaplastic largecell lymphoma.
Oulu University Hospital is searching a hyperthermia perfusion pump suitable for open HIPEC (hyperthermic intraperitoneal chemotherapy) after cytoreductive surgery for perioneal malignancies.